These data demonstrate that ERBB4 expression is modestly reduced in breast cancer tissues and that its expression is inversely correlated to cancer progression, thus suggesting that ERBB4 may act as a tumor suppressor in breast cancer patients. This evidence concerns the gene ERBB4 and breast cancer.